| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr10_0276400 | Intergenic-Intergenic | chr10:31791384-31799631 | chr10:31502456-31510703 | 37 nt | 0.4054 |
| hsa_ZEB1_0021500 | Intron-Intron | chr10:31791456-31799347 | chr10:31502528-31510419 | 160 nt | 0.3625 |
| hsa_ZEB1_0021600 | Intron-Intron | chr10:31791480-31799347 | chr10:31502552-31510419 | 136 nt | 0.3676 |
| hsa_ZEB1_0021700 | Exon-Exon | chr10:31799601-31803636 | chr10:31510673-31514708 | 106 nt | 0.3868 |
| hsa_chr10_0276600 | Intergenic-Intergenic | chr10:31799632-31803608 | chr10:31510704-31514680 | 250 nt | 0.3840 |
| hsa_ZEB1_0021800 | Exon-Exon | chr10:31809245-31809721 | chr10:31520317-31520793 | 477 nt | 0.4046 |
| hsa_chr10_0276700 | Intergenic-Intergenic | chr10:31809717-31810036 | chr10:31520789-31521108 | 320 nt | 0.4188 |
| hsa_chr10_0276800 | Intergenic-Intergenic | chr10:31809767-31810120 | chr10:31520839-31521192 | 354 nt | 0.4266 |
| hsa_chr10_0276900 | Intergenic-Intergenic | chr10:31810647-31810794 | chr10:31521719-31521866 | 148 nt | 0.4932 |
| hsa_ZEB1_0021900 | Exon-Exon | chr10:31812889-31816088 | chr10:31523961-31527160 | 642 nt | 0.4377 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].